FDA Inspection
Bioasia Worldwide Sdn BhdBioasia Worldwide Sdn Bhd – FDA Inspection, Oct 17, 2024
Record Details
This FDA Inspection record concerns Bioasia Worldwide Sdn Bhd, with an inspection on October 17, 2024, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · f34cf55e-127c-46fb-b7ea-9d559a2be535
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1252128
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
12- 21 CFR 211.166(b)Accelerated stability studies
- 21 CFR 211.165(b)Microbiological testing
- 21 CFR 211.25(a)Training--operations, GMPs, written procedures
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.84(d)(2)Establish reliability of supplier"s C of A
- 21 CFR 211.67(b)(3)Cleaning SOPs/instructions
- 21 CFR 211.170(b)Annual visual exams of drug products
- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.84(d)(1)Identity Testing of Each Component
- 21 CFR 211.180(e)(1)Review of representative number of batches
Showing 10 of 12 citations.
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.